Results 101 to 110 of about 232,782 (169)
Clinical and molecular heterogeneity in advanced-stage <i>POLE</i>-mutated endometrial carcinoma: a focus on aggressive subsets and co-mutations. [PDF]
Front OncolCavasin N, Kilzie S, Vinci M, Trozzi R, Nero C, Restaino S, Cassani C, Pignata S, Pisano C, Scibilia G, Fruscio R, Mancari R, Favaretto A, Fassan M, Toffolatti L, Gallina G, Fanfani F, Salutari V, Artioli G. +18 moreeuropepmc +1 more sourceCorrection: Sars-Cov-2 spike protein and plasma from COVID-19 patients induce extracellular traps by myeloid-derived suppressor cells. [PDF]
Front Cell Infect MicrobiolGrassi G, Gili S, Casetti R, Percario ZA, Tumino N, Vacca P, Lamsira HK, Nardacci R, Notari S, Bordoni V, Cimini E, Cristofanelli F, Rubino D, Nonini F, Affabris E, Marchioni L, Agrati C, Sacchi A. +17 moreeuropepmc +1 more sourceA Gut Feeling: An Exploratory Multi-Omics Study of Gut Microbiome Dysbiosis and Metabolome and Lipidome Alterations in GATA2 Deficiency. [PDF]
Int J Mol SciRoncareggi S, Fioredda F, Girardi K, Serrao S, Capitoli G, Fumagalli R, Nobile M, Fazio G, Guerra F, Valsecchi MG, Rebellato S, Casillo M, Fantuz MR, Savarese G, Paglia G, Gambineri E, Balduzzi AC, Biondi A, Saettini F, Italian GATA2 Study Group. +19 moreeuropepmc +1 more sourceImpact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study. [PDF]
Front OncolPantano F, Malgeri A, De Giorgi U, Maruzzo M, Fornarini G, Zucali P, Fratino L, Milella M, Pedrazzoli P, Procopio G, Stellato M, Naglieri E, Soto Parra H, Napoli MD, Mollica V, Tudini M, Pipitone S, Santoni M, Ricotta R, Banna GL, Catalano F, Cavo A, Vignani F, Masini C, Casadei C, Galli L, Nolè F, Sorarù M, Prati V, Panni S, Roviello G, Prati G, Morelli F, Messina C, Atzori F, Rescigno P, Santini D, Buti S, Rebuzzi SE. +38 moreeuropepmc +1 more sourceCorrection: Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis. [PDF]
Mol NeurodegenerPasetto L, Callegaro S, Corbelli A, Fiordaliso F, Ferrara D, Brunelli L, Sestito G, Pastorelli R, Bianchi E, Cretich M, Chiari M, Potrich C, Moglia C, Corbo M, Sorarù G, Lunetta C, Calvo A, Chiò A, Mora G, Pennuto M, Quattrone A, Rinaldi F, D'Agostino VG, Basso M, Bonetto V. +24 moreeuropepmc +1 more sourceReal-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort. [PDF]
Blood AdvMartino EA, Pitino A, Vigna E, Pasquale R, Ferrarini I, Moia R, Visentin A, Sanna A, Motta M, Moratti M, Sportoletti P, Chiarenza A, Maggi A, Zammit V, Merli M, Innocenti I, Giordano C, Nocilli L, Postorino M, Stelitano C, Ferrario A, Frustaci AM, Riva M, Pepe S, Ibatici A, Scardino S, Anticoli Borza P, Ballotta L, Mancuso S, Malaspina F, Mele A, Galimberti S, Catania G, Giordano A, Angeletti I, Schiattone L, Pennese E, Miccolis R, Fama A, Giordano G, Califano C, Bruzzese A, Caserta S, Farina G, Bulian P, Loseto G, Pocali B, Innao V, Galieni P, Fraticelli V, Vitale C, Romeo A, Rossi M, Scortechini I, Vozella F, Malandruccolo L, Varettoni M, Morello L, Pietrantuono G, Conte E, Cantelli M, Murru R, Caracciolo D, Derenzini E, Di Martina V, Marasca R, Del Principe MI, Figuera A, Angotzi F, Coscia M, Di Renzo N, Laurenti L, Amodio N, Musto P, Di Raimondo F, Liso A, Tedeschi A, Trentin L, Gaidano G, Mauro FR, Tripepi G, Morabito F, Gattei V, Gentile M. +83 moreeuropepmc +1 more source